Regorafenib vs trifluridine/tipiracil for metastatic colorectal cancer refractory to standard chemotherapies: A multicenter retrospective comparison study in Japan

Regorafenib (REG) and trifluridine/tipiracil (FTD/TPI) showed survival benefits in metastatic colorectal cancer patients previously treated with standard chemotherapies; therefore, we compared the efficacy and safety of these two treatments. Patients with metastatic colorectal cancer treated with RE...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Main Authors: Ogata, Misato, Kotaka, Masahito, Ogata, Takatsugu, Hatachi, Yukimasa, Yasui, Hisateru, Kato, Takeshi, Tsuji, Akihito, Satake, Hironaga
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2020
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7292354/
https://ncbi.nlm.nih.gov/pubmed/32530932
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0234314
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares